Related Experiment Video
Updated: Jun 15, 2025
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Mucormycosis in an Immunocompetent Patient Recovering From Dengue Fever
Sushmitha D J1, Kalyan Kumar Reddy Annapureddy2, Nishan Poojary1
1Otolaryngology, ClearMedi Radiant Hospital, Mysuru, IND.
Abstract:
Mucormycosis is a rare yet aggressive fungal infection. Despite its rarity, India has experienced a surge in cases during the post-COVID-19 era. The high mortality rate associated with this infection necessitates early diagnosis, intervention, and aggressive treatment. Typically, it is observed in immunocompromised patients, where the disease progresses rapidly and leads to unfavorable outcomes. However, occurrences in previously healthy individuals are not uncommon. Dengue has been occasionally associated with mucormycosis in the post-recovery phase. This case report highlights the importance of heightened clinical suspicion and early intervention in patients with recent dengue infections and chronic sinus conditions. It explores potential risk factors, such as dengue-related immune alterations, environmental exposures, and anatomical alterations that may contribute to the development of mucormycosis in otherwise healthy individuals.
Insights
Mucormycosis, a severe fungal infection, is rising in India post-COVID-19. Early detection and treatment are crucial, especially in dengue patients with sinus issues, even if healthy.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- Mucormycosis is a rare, aggressive fungal infection with high mortality.
- It predominantly affects immunocompromised individuals but can occur in healthy people.
- A surge in mucormycosis cases has been observed in India during the post-COVID-19 period.
Observation:
- Dengue infection has been linked to mucormycosis in the post-recovery phase.
- This case report focuses on patients with recent dengue and chronic sinus conditions.
- Mucormycosis development in healthy individuals is explored.
Findings:
- Dengue-related immune alterations may increase mucormycosis risk.
- Environmental exposures and anatomical sinus variations are potential contributing factors.
- Heightened clinical suspicion is vital for early diagnosis in at-risk patients.
Implications:
- Early intervention strategies are critical for improving outcomes in mucormycosis.
- Understanding risk factors in dengue patients can guide preventative measures.
- Further research is needed to elucidate the link between dengue and mucormycosis.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...